NOTE 10: Earnings/Loss per Share Because we reported a net loss for all periods presented, no potentially dilutive securities have been included in the computation of diluted net loss per share. | | | Three months ended | | | | | March 31, | | | | | 2026 | | | 2025 | | | Numerators: | | | | | | | | Net loss attributable to common stockholders | | $ | (276 | ) | | $ | (555 | ) | | Denominator: | | | | | | | | | | Weighted Average shares used to compute basic and diluted net loss per share | | | 220,627,022 | | | | 112,637,822 | | | Basic and diluted net loss per share | | $ | (0.00 | ) | | $ | (0.00 | ) | | | | Six Months Ended | | | | | March 31, | | | | | 2026 | | | 2025 | | | Numerators: | | | | | | | | Net loss attributable to common stockholders | | $ | (10,421 | ) | | $ | (30,099 | ) | | Denominator: | | | | | | | | | | Weighted Average shares used to compute basic and diluted net loss per share | | | 213,834,502 | | | | 105,306,664 | | | Basic and diluted net loss per share | | $ | (0.05 | ) | | $ | (0.29 | ) | The following potential common stock outstanding were excluded from the computation of diluted net loss per share because including them would have been anti-dilutive: | | | March 31, 2026 | | | September 30, 2025 | | | Options to purchase Class B common stock | | | 2,137,384 | | | | 6,623,330 | | | Unvested RSAs | | | 73,500 | | | | - | |
|